Wednesday, 29 May 2019

What is the latest international consensus definition for the ultrasound assessment of the PCO ?


The polycystic ovary should have at least one of the following: either 12 or more follicles measuring 2-9 mm in diameter or increased ovarian volume (>10 cm3). If there is evidence of a dominant follicle (>10 mm) or a corpus luteum, the scan should be repeated the next cycle.
The subjective appearance of polycystic ovaries should not be substituted for this definition. The follicle distribution should be omitted as well as the increase in stromal echogenicity and/or volume. Although the latter is specific to PCO, it has been shown that the measurement of the ovarian volume is a good surrogate for the quantification of the stroma clinical practice.
Only one ovary fitting this definition or a single occurrence of one of the above-mentioned criteria is sufficient to define the PCO. If there is evidence of a dominant follicle (>10 mm) or corpus luteum, the scan should be repeated the next cycle. The presence of abnormal cysts or ovar­ian asymmetry, perhaps suggesting a homogeneous cyst, necessitates fur­ther investigation.
This definition does not apply to women taking the oral contraceptive pill, as ovarian size is reduced, even though the polycystic appearance may persist.
A woman having PCO in the absence of an ovulation disorder or hyperan­drogenism (asymptomatic PCO) should not be considered as having PCOS, until more is known about this situation.


In addition to its role in the definition of PCO, ultrasound is helpful to pre­dict fertility outcome in patients with PCOS (response to clomifene citrate, risk for ovarian hyperstimulation syndrome (OHSS), decision for in vitro maturation of oocytes). It is recognised that the appearance of PCOs may be seen in women undergoing ovarian stimulation for IVF in the absence of overt signs of the PCO syndrome. Ultrasound also provides the opportunity to screen for endometrial hyperplasia following technical recommendations should be respected.

Do you know that Ovarian stromal volume has been correlated with serum Testosterone concentrations ?


Therefore The diagnosis of PCO is best made not on the clinical presentation but rather on the ovarian morphology.
. There have been many attempts to redefine the morphological appearance of the PCO by using transvaginal ultraso­nography, three-dimensional transvaginal ultrasonography and magnetic resonance imaging. It is now known that ovarian stromal volume has been correlated with serum Testosterone concentrations   and may provide more useful informa­tion then the volume of the cysts. Furthermore, ovarian volume correlates well with stromal volume as a marker of hyperandrogenism and is easier to measure in practice than stromal volume . Ovarian volume is usually greater than 10 ml, compared with the normal ovarian volume of ml.

Tips of differentiating between PCO and PCOS



It is important to differentiate between PCO and the PCOS. PCO describes the  morhological appearance of the ovary whereas PCOS is only appropriate when PCOs  are round in association with a menstrual disturbance (amenorrhoea or, more commonly, oligomenorrhoea) and/or the complications of hyperandrogenism (acne and hirsutism, PCOS also is associated with endocrinological abnormalities and, in particular, with elevated serum concentrations of androgens (T, androstenedione) and LH. As with the clinical picture, these changes are variable and patients with PCOS may have normal endocrine concentration.

How do you see the image of a classical PCO Ovaries (one side or both sides)?

Polycystic ovaries are a separate entity and have a distinct response to induction of ovulation and ovarian stimulation for IVF. The association of enlarged, sclerocystic ovaries with amenorrhoea, infertility and hirsutism was first described by Stein and Leventhal in 1935, and it is now known as PCOS. Since then, it has become apparent that polycystic ovaries may be present in women who are non-hirsute and who have regular menstrual cycles. Thus, a clinical spectrum exists between the typical Stein—Leventhal picture (PCOS) and the symptomless (PCO). Even patients described as having the PCOS exhibit considerable heterogeneity.

Pelvic Ultrasound: Basal Scan-& Findings at Basal endocrine evaluations & treatment thereof Pelvic Ultrasound.

 First do abdominal scan even you are very expert in TVS. The reason is as follows :-When first scanning the pelvis, many radiographers and radiologists suggest per¬forming a transabdominal scan to first obtain an overview of the pelvic organs, and second to assess the kidneys and renal tract if indicated. Subsequently, a transvaginal ultrasound examination of the pelvic organs is preferred to the transab¬dominal approach as it not only obviates the need for a full bladder with its associated Discomfort but also allows high-frequency probes (5-7.5 MHz) to be used so that higher resolution and greater precision in measurements or measurements of the pelvic structures, follicular diameters and endometrial thickness be achieved. It is especially advantageous in patients who are undergoing assisted conception as they commonly have lower abdom¬inal scars that impair the penetration of ultrasound; furthermore, periadnexal adhe¬sions may tether the ovaries deep in the pelvis and limit the elevation of these structures that normally occurs when the bladder is filled for a transabdominal scan. A study the follicles were more sharply defined in 90% of cases when the transvaginal approach was used compared with only 41% with a transabdominal approach [21]. The same study found that the numbers and sizes of the dominant follicles correlated better with the serum oestradiol concentrations when transvaginal scanning was used.
An ultrasound assessment of ovarian volume and AFC in the early follicular phase has been used as a predictor for ovarian response before IVF treatment, with small-volume ovaries indicating reduced ovarian reserve

How do you treat OHSS?


TR of OHSS- Please admit the case in ICU and involve Internist for proper monitoring and to avoid death. This is a hypercoagulable state along with release of VEGF and lots of hemodilution and there is loss of fluid into extra cellular space with formation of ascites/ Trannsudate from ovaries hypoprotineamia with low urine output.
(1)    Intake output chart 20 % albumin infusion (Haemlog) - hydrate well / ringer solution it is a hyper coagulable state ,  Pulse, BP, Temperature, Pulse oximtery- Oxygen saturation, Avoid Catheter so that no UTI occurs, Daily Body wt record and also record dally abdominal girth, listen to lungs for creps, avoid lasix and mannitol(Better restrict IV fluid)
(2)     Electrolyte balance, daily CBC, BT CT, Platelate
(3)    PCV=Haematocrit,-must be kept below 55%,  
(4)    Central line for recording of Arterial pressure
(5)    Central Venous Pressure
(6)    Pan- D IV, Zofer tablet to prevent vomiting
(7)    Avil 25 mg TDS 
(8)    Renal. Hepatic Function tests
(9)     Serum creatinine must be < 1.5 mg.
(10)           Peritoneal Tap in severe cases
(11)           Use Inotrops if BP and Urine output is low- noradereline micro drip ( Pre adjusted- Drip 30 minute basis depending upon rise of fall BP), Carbon dioxide retention in the system has to be taken care of by the ICU nurse.
(12)           Antagonist and cabergolin and LMWH (Must)
(13)           Daly USG particularly look for hepatorenal pouch of Morrison for any fluid.
Specific TR: - Rehydration, -by NS or Hartmann solution, TR of hypotension, Crystalloids. If crystalloids do not improve the condition thenà Dextrin, Fresh Frozen Palm, or Low salt Albumin, No diuretics except persistent oliguria inspite of full hydration of Pt. Anticoagulation: if coagulation profile sosuggests.

Tuesday, 28 May 2019


Physiological changes in pregnancy Hepatic synthesis of thyroid binding globulin is increased
Total levels of thyroxin and triodothyronine are increased to compensate for this rise
Level of free T4 are altered less by pregnancy but do fall a little in the second and third trimesters
Serum concentration of thyroid stimulating hormone initially rise and then fall in the first trimester and the normal range is wider than in the nonpregnant .
Hyperemesis gravidarum may be associated with a biochemical hyperthryroidism with high levels of free T4 and a a suppressed TSH  up to 60% of cases. This relates to increased concentration of human chorionic gonadotrophin.   hCG has thyrotrophic activity .
In the second and third trimesters. TSH levels increase so the upper limit of the reference rqange is raised compared with those in the non pregnant woman
Similarly the normal ranges for free T4 and T3 are reduced. Compared to outside pregnancy free T4 has a narrower and lower range and falls throughout pregnancy.
TSH levels used in isolation are unreliable in pregnancy for the assessment of thyroid status.
Pregnancy is associated with as state of relative iodine deficiency that has two major cases:
1.       Maternal iodine requirements increase because of active transport to the fetoplacental unit.
2.       2. Iodine excretion in the urine is increased twofold because of increased glomerular filtration and decreased renal tubular reabsorption.
3.       Because the plasma level of iodine falls the thyroid gland increases its uptake from the blood threefold.
If there is already dietary insufficiency of iodine the thyroid gland hypertrophies in order to trap a sufficient amount of iodine.
Pregnancy specific normal ranges or TFTs

TSH
Thyroxine
Tri iodothyronine
Non- pregnant
0.27-4.2
12-22
3.1-6.8
First trimester
0-5.5
10-16
3-7
Second trimester
0.5-3.5
9-15.5
3-5.5
Third trimester
0.5-4
8-14.5
2.5-5.5

Biochemical assessment of thyroid function in pregnancy should include assays of free T4 and in   some cases free T3 . Immunoradiometric assays of TSH are useful but should not be used in isolation because of the variable effects of gestation.
Pattern of abnormality
Possible diagnoses
Comments/further investigation versus normal non-pregnant ranges in women
Total T4
Total T3
Normal free T4
Normal TSH
Normal in pregnancy
Refer to normal   ranges for pregnancy
Free T4 (mild)
TSH (mild)
Normal in third trimester
Mild hypothyroidism
Refer to normal ranges for third trimester
Check thyroid autoantibodies
Normal free T4 TSH
May be normal feature in early first trimester May represent sub clinical hypothyroidism possibly with poor compliance
Repeat thyroid function tests in second trimester check thyroid autoantibodies
TSH may remain high in the initial phases of treatment of hypothyroidism
Free T4 TSH
May be associated with hyperemesis in the absence of nausea or vomiting or in association with other symptoms preceding pregnancy or thyroid eye disease suggests thyrotoxicosis
Does not require treatment if due to Hyperemesis
Abnormality resolves with improvement in Hyperemesis
Check thyroid stimulating antibodies to help confirm diagnosis of thyrotoxicosis and assess risk of fetal hyperthyroidism
TSH
Free T4
Secondary or tertiary hypothyroidism or non thyroidal illness
Both secondary and tertiary hypothyroidism are rare
Normal free T4
Treated thyrotoxicosis possibly with an intermittently compliant patient
May be a normal feature in first trimester
TSH remains suppressed in the initial phases of treatment of hyperthyroidism
Repeat thyroid function tests in second trimester.

Sunday, 26 May 2019

Can stsin help in risk reduction of cardio vascular diseases in PCO cases with dydlipidaemia?


How many members use stains in teenage PCO if there is marked dyslipidaemia??

Ans: This raises a question is it worthy to prescribe such drug when hepatic enlargement is not uncommon (Fatty liver). How should one balance the risk of stating induced myopatly albeit  rare.Does stain have any long term beneficial effect Ion risk reduction in the form of CVD prevalence .Does stain prevent prevalence or magnitude of CVD in later life?What does the evidence say?? 

What is known about PCO;-We are aware of the  fact that high levels of serum androgens (male hormone) are one of the main features of PCOS.
 women with polycystic ovary syndrome (PCOS) usually suffer from  irregular periods, excessive hair growth (hirsutism) and acne (pimples).

How many members use statins in PCO when there is dyslipidaemia at post pubertal age due to PCO to curtail CVS risk in later life? We know post-pubertal girls who are having Oligomenorrhoea, overweight along with F/H/O of DM are at a higher risk of Metabolic syndrome & CVD in of 4th/5th th  decade of life . But the magnitude of risk(how early will the and how severely the woman will be affected but the fact remains that OGTT is a better guide for glycemic status of adolescent PCO abd Lipid profile to forewarn the parents about diet  &  exercise).
Ans 2:-There is no good evidence from different long term studies that `   :-
Statins improve menstrual regularity, spontaneous ovulation rate, hirsutism or acne, either alone or in combination with the combined oral contraceptive pill.
 There is also no good evidence that statins have a beneficial effect on hirsutism or acne (pimples) associated with PCOS.
But the plus point is :-- In women with PCOS, statins are effective in reducing serum androgen levels and decreasing bad cholesterol (LDL), but
statins are not effective in reducing fasting insulin or insulin resistance. There is no good evidence available on the long-term use of
statins (alone or in combination) for the management of PCOS.



Friday, 24 May 2019


Of all the three measure causes of sub fertility three important factors are ...
A. Late Marriage
B. Environmental pollutions and liberal use of  pesticides in the green vegetables whatever we purchase and consumes- food and bad cooking habits leading to formation of AGE (Endocrine disruptors) and thirdly
C. Husband and wife remain separated of income purpose – Intrastate or interstate migration for jobs

Many males are now employed gainfully in different district or different states or union territory of our mother land leaving behind their young wife to take care of elderly parents and possible cattle’s . in such cases it will be very essential if a women can anticipate ferial period well ahead so that husband can come at a short notice. However can be calculated from previous cycles lengths, serial cervical mucus test. LH urinary kit is only applicable where husband is employed with in 200 KM of her residence so that a railway or bus ticket are easily available  Position of calculating day of ovulation in human beings where as in animals only copulation brings out ovulation.
What do we mean by “fertile window .It is time to change: Is our existing idea on timing of ovulation is wrong?? What do we mean by “fertile window and shall we change the definition after being used for long 50-70 years.”?? Is our existing idea on timing of ovulation is inaccurate /wrong?? How is the concept that ovulation occurs from day 10-16 in normally spontaneously Ovulatory women so that timed coitus may be planned when husband is employed outside the home town or one depends on withdrawal method of contraception as method  of   Natural Family planning. The fertile window may last between 1 day and 5 days and the chance of natural pregnancy is signifi­cantly greater the longer it lasts. For example, when the fertile window is only 1 day, the fecund ability ratio is 0.11 compared with 2.4 when it lasts for 5 days. Wilcox et al. estimated that A) 2% of women were in their fertile period by day 4 of their cycle, B) 17% by day 7 and C) 54% by day 12. Most women appear to reach their fertile window early in the cycle, although a proportion does so much later, even past day 35.

Abnormal hair growths in women causes

Googly:-  Not all hairs in a young women are due to androgens

High serum level of androgens neither the excess hairs are due to more androgens receptors. answer by 20 second and win a cash prize of Rs. 0.05/- by the year 2060 positively.  Which area of body responds to only high dose of androgens and mandate thorough investigation??
-Hairs in the following this area cannot be considered as due to PCOS or physiological. Tumours of adrenal /Ovary remain a great possibility. Follicles in the distribution associated with male patterns of facial and body hair (midline, facial, inframammary) require higher levels of androgens, as seen with normal testicular function or abnormal ovarian or adrenal androgen production.
Androgen effects on hair vary in relation to specific regions of the body surface. Hair that shows no androgen dependence includes lanugo, eyebrows, and eyelashes.
 A).The hair of the limbs and portions of the trunk exhibits minimal sensitivity to androgens.
B)AXilla and pubic region Pilosebaceous units of the axilla and pubic region are sensitive to low levels of androgens, such that the modest androgenic effects of adult levels of androgens of adrenal origin are sufficient for substantial expression of terminal hair in these areas.
C). Scalp hair is inhibited by gonadal androgens, in varying degrees, as determined by age and genetic determination of follicular responsiveness, resulting in the common frontal-parietal balding seen in some males and in virilized females. Hirsutism results from both increased androgen production and skin sensitivity to androgens.
Skin sensitivity depends on the genetically determined local activity of 5a-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT) the bioactive androgen in hair follicles.


Brush up your knowledge on genl surgery if U were absent from clinics and was gossiping with someone special at canteen at 7th semester!!!


Fibroadenoma is a very common benign breast condition. The most common symptom is a lump in the breast which during a clinical breast exam, you or  doctor will check both breasts for lumps and other problems. Some fibroadenomas are too small to feel, so they can only be discovered in imaging tests.

If you have a lump that can be felt (palpable), it will be wise t go ahead with some tests and those tets depends /or procedures, will depend on her age and the characteristics of the lump.

What is etiology ?  OBJECTIVE
To identify from the literature and clinical experience a rational approach to management of fibroadenomas of the breast.
METHOD
Recent literature on detection, diagnosis, and natural history of fibroadenomas was reviewed. Experience with over 4,000 women evaluated in the breast clinic at the Tel- Aviv Medical Center contributed to the management strategies suggested by review of the literature.
RESULTS
Fibroadenomas of the breast are common, accounting for 50% of all breast biopsies performed. Physical examination, sonography, and fine needle aspiration are effective in distinguishing fibroadenomas from breast cancer. Transformation from fibroadenoma to cancer is rare; regression or resolution is frequent, supporting conservative approaches to follow-up and management.
CONCLUSION
Age-based algorithms that allow for conservative management and that limit excision to patients whose fibroadenomas fail to regress are presented.
Keywords: fibroadenoma, breast neoplasms, women
Fibroadenomas are common benign lesions of the breast that usually present as a single breast mass in young women. They are assumed to be aberrations of normal breast development or the product of hyperplastic processes, rather than true neoplasms.
How to examine Breasts at Exam Hall ??  If male candidate ask ward Nurse to be present and be polite,& courteous to woman concerned,Show & practice as U practice how best to palpate  thyroid, Axillary glands!!
Dilemma & Dilemma; To do or not to do:After a clinical diag of Fibroadenoma you now have two options like Breast sonography & FNAC,I leave it to members,-The clinician often faces the dilemma whether to remove the mass or to monitor it by means of periodic follow-up examinations.
Adv of removal:-Although removal of these lesions is a definitive solution,
 Disadvantages of surgery: surgery may involve 1) unnecessary excisions of benign lesions and2) unbecoming cosmesis. Moreover, a policy of conducting surgery on all patients with fibroadenomas would place an 3) enormous burden on health care systems.


Then  whom to vote for ?? What is in your back of mind?? Thinking:1:- Cancer probality in near future. Or no cancer?? That lurks in one’s mind,. A balanced and rational approach to the management of a   fibroadenoma of the breast needs to address the crucial questions about its association with breast cancer, especially whether or not it is a marker of increased risk of breast malignancy. Another consideration to be weighed is that a Thinking: 2 :-A  substantial percentage of these lesions undergo spontaneous regression. Herein, based on our review of the current data on fibroadenomas of the breast and our experience, we propose practical algorithms for their management.
What is the prevalence.  More common in young women. Fibroadenomas usually form during menarche (15 –25 years of age), a time at which lobular structures are added to the ductal system of the breast There are no clear-cut data on the incidence of fibroadenomas in the general population. In one study, the rate of occurrence of fibroadenomas in women who were examined in breast clinics was 7% to 13%  while it was 9% in another study of autopsies. Fibroadenomas comprise about  A) 50% of all breast biopsies, and this rate rises to B)  75% for biopsies in women under the age of 20 years. Fibroadenomas are more frequent among women in  C) higher socioeconomic classes  and in dark-skinned populations.

Can I take OCP:_Yes, no restrictions in presence Fibroadenoma. The age of menarche, the age of menopause, and hormonal therapy, including oral contraceptives, were shown not to alter the risk of these lesions.,
Whoch factors discourages development of fibroadenoma?? body mass index and the number of full-term pregnancies were found to have a negative correlation with the risk of fibroadenomas., Moreover, consumption of large quantities of vitamin C and  surprisingly cigarette smoking were found to be associated with reduced risk of a fibroadenoma.
No genetics factors are known to alter the risk of fibroadenoma. However, a family history of breast cancer in first-degree relatives was reported by some investigators to be related with increased risk of developing these tumors.
At What  age this initiates??   Fibroadenomas usually form during menarche (a time at which lobular structures are added to the ductal system of the breast . Hyperplastic lobules are common at that time, and may be regarded as a normal phase of breast development.  Hyperplastic lobules were shown to be histologically identical with fibroadenomas.  .Analyses of the cellular components of fibroadenomas by means of polymerase chain reaction demonstrated that both the stromal and the epithelial cells are polyclonal supporting the theory that fibroadenomas are hyperplastic lesions associated with aberration of the normal maturation of the breast, rather than true neoplasms.

1
Histologic section of a fibroadenoma (hematoxylin-eosin staining, × 40). The cellular fibroblastic stroma, which resembles intralobular stroma, encloses glandular and cystic spaces lined by epithelium. Round and oval gland spaces, lined by either single or multiple cell layers, are present in other areas. The stroma in the connective tissue appears to have undergone a more active proliferation with compression on the gland spaces.
The pattern of stromal growth in a fibroadenoma depends on its epithelial component: stromal mitotic activity was found to be higher near this component.1 Fibroadenomas are stimulated by estrogen and progesterone, and by lactation during pregnancy, and they undergo atrophic changes in menopause. Some fibroadenomas have receptors and respond to growth hormone and epidermal growth factor.
Clinical presentation of a classical fibroadenoa
A fibroadenoma is most often detected incidentally during a medical examination or during self examination, usually as a discrete solitary breast mass of 1 to 2 cm.Although they can be located anywhere in the breast, the majority are situated in the upper outer quadrant.A fibroadenoma is usually smooth, mobile, nontender, and rubbery in consistency Several other breast lesions have similar characteristics, and physical examinations provided an accurate diagnosis in only one half to two thirds of cases studied.However, most of the masses that are erroneously diagnosed by palpation as fibroadenomas are found on histologic examination to be another benign form of breast disease such as cystic fibrosis.


Macroscopic appearance of a fibroadenoma. The spherical mass is sharply circumscribed, and could be easily separated from the surrounding breast tissue. The section margins have a green-white color, and contain slit-like spaces.
Multiple Fibroadenomas
From 10% to 16% of patients with multiple fibroadenomas have two to four in a single breast, which may present initially or be discovered over several years. Unlike women with a single fibroadenoma, most of the patients with multiple fibroadenomas have a strong family history of these tumors. A possible connection between multiple fibroadenomas and oral contraceptives was proposed but has not yet been substantiated.
Fibroadenomas larger than 5 cm (about 4% of the total) are commonly defined as being giant fibroadenomas; however, this terminology is not universally accepted. Giant fibroadenomas are usually encountered in pregnant or lactating women. When found in an adolescent girl, the term juvenile fibroadenoma is more appropriate. These lesions in young women constitute 0.5% to 2% of all fibroadenomas, and are rapidly growing masses that cause asymmetry of the breast, distortion of the overlying skin, and stretching of the nipple. Histologically, they appear to be more cellular and have less lobular components than do simple fibroadenomas. However, giant fibroadenomas are benign lesions that do not undergo transformation into malignancy.Sonography
Breast sonography is often used for the diagnosis of fibroadenomas. The sonographic criteria that support the diagnosis of a fibroadenoma are a round or oval solid mass with a smooth contour and weak internal echoes in a uniform distribution and intermediate acoustic attenuation . This imaging technique is very useful for differentiating between solid and cystic lesions. However, attempts to correlate between the sonographic features of solid masses compatible with fibroadenomas and pathologic findings were disappointing. There is some overlap in the sonographic criteria for fibroadenomas and for breast cancer, and approximately 25% of fibroadenomas appear with irregular margins, which may imply that the lesions are malignant. Also, only 82% of biopsy-proven fibroadenomas were visualized by sonography in one study.


Sonographic appearance of a fibroadenoma. The mass is homogenous, with sharp and smooth margins. Slight posterior and edge enhancements are visible. Neither compression effects nor internal echoes are present.
Mammography
The yield of mammography in young women is low, and its role in the diagnosis of fibroadenomas is limited. However, it may disclose features of infiltrative lesions in older women. In the mammographic image, fibroadenomas appear as soft, homogenous, and well-circumscribed nodules, and inner coarse calcifications are often observed.
Fine needle aspiration (FNA) has become a popular method in the evaluation of breast masses. The characteristic cytologic features of fibroadenomas are: clusters of spindle cells without inflammatory or fat cells, found in 96% of all fibroadenomas; aggregates of cells with a papillary configuration resembling elk antler (antler horn clusters), found in 93% of all cases; and uniform cells with well-defined cytoplasm lying in rows and columns (honeycomb sheets), found in 95% of all fibroadenomas.32 Taken together with the clinical diagnosis of fibroadenoma, FNA can improve the sensitivity of the diagnosis to 86% with a specificity of 76%, while for breast cancer FNA is 96% sensitive and 98% specific. Thus, while aspiration cytology may confuse fibroadenomas with other benign breast lesions, incorrect diagnosis of a malignant process is rare.
The overall diagnostic efficacy of these three modalities—namely, manual breast examination, imaging and cytology is approximately 70% to 80%, but they provide a 95% (±2% SD) accurate differentiation between a benign and a malignant lesion. A follow-up period of 1 to 3 years after fibroadenoma is diagnosed and breast cancer is excluded using the three modalities can enhance the accuracy of the diagnosis.